#nanocovax

 Results from the phase 3a clinical trial of the domestically-produced COVID-19 vaccine Nanocovax on more than 1,000 volunteers have been adopted by the National Biomedical Research Ethics Council (NBREC).

Vietnam is hopeful it can produce its first local COVID-19 vaccine this year, with the third trial phase of trials for the NanoCovax vaccine set to be completed in late September while the COVIVAC vaccine will enter the second phase by the end of June, according to the Ministry of Health (MoH).

PSNews - According to the Vietnam Military Medical Academy, the highest dose (75mcg) of Nanocovax COVID-19 vaccine , developed by Vietnam, was given to three volunteers in Hanoi on January 12 as part of the first stage of human trials.

PSNews - Vietnam on December 17 began human trials of the country's first COVID-19 vaccine as three volunteers received their first doses of Nanocovax at the Military Medical University in Hanoi.

PSNews – The clinical trials will end in early May 2021, and after that the mass production of “Made-in-Vietnam” COVID-19 vaccine will start, said Mr. Ho Nhan, Chairman of NANOGEN on December 10.

PSNews – The National Ethics Council for Biomedical Research under the Ministry of Health approved phase 1 and phase 2  human trials of the Nanocovax COVID-19 vaccine produced by NANOGEN Company in collaboration with the Military Medical University.